Lesson Description
The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) hosted a virtual scientific public workshop on February 25, 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop was to identify and discuss the current state of the science, development, and regulation for cellular therapies and tissue-based products.
In this session, the workshop is closed by thoughts from:
- Heather Lombardi, PhD, OCTHT, OTP, CBER, FDA
- Sally Temple, PhD, Scientific Director, The Neural Stem Cell Institute